Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

ASMB

Assembly Biosciences Inc

Dec 10 • 04:00PM ET

16.11

Dollar change -0.58
Percentage change -3.50	%

Healthcare • Biotechnology • USA • NASD

Peers: GILD ABUS IONS ENTA MDGL NBIX VKTX ADAP OMER LXRX

| Held by: VTI VXF FESM IWC AVUV DFAC DCOR AVSC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-7.14	Insider Own	29.70%	Shs Outstand	6.35M	Perf Week	-1.77%
Market Cap	102.40M	Forward P/E	-	EPS next Y	-7.33	Insider Trans	2.27%	Shs Float	4.47M	Perf Month	-3.99%
Income	-40.80M	PEG	-	EPS next Q	-1.97	Inst Own	16.17%	Short Float	0.36%	Perf Quarter	-7.31%
Sales	28.33M	P/S	3.61	EPS this Y	45.86%	Inst Trans	-17.51%	Short Ratio	0.48	Perf Half Y	4.41%
Book/sh	4.09	P/B	3.94	EPS next Y	-1.24%	ROA	-53.73%	Short Interest	0.02M	Perf Year	76.64%
Cash/sh	14.94	P/C	1.08	EPS next 5Y	17.00%	ROE	-120.51%	52W Range	8.43 - 19.93	Perf YTD	63.70%
Dividend Est.	-	P/FCF	4.48	EPS past 5Y	22.47%	ROI	-156.24%	52W High	-19.17%	Beta	0.56
Dividend TTM	-	Quick Ratio	2.36	Sales past 5Y	42.26%	Gross Margin	99.36%	52W Low	91.08%	ATR (14)	0.95
Dividend Ex-Date	-	Current Ratio	2.36	EPS Y/Y TTM	58.31%	Oper. Margin	-163.94%	RSI (14)	48.64	Volatility	4.15% 6.07%
Employees	65	Debt/Eq	0.06	Sales Y/Y TTM	-	Profit Margin	-144.05%	Recom	1.67	Target Price	35.50
Option/Short	No / Yes	LT Debt/Eq	0.00	EPS Q/Q	54.02%	Payout	-	Rel Volume	1.28	Prev Close	16.69
Sales Surprise	18.70%	EPS Surprise	34.44%	Sales Q/Q	-	Earnings	Nov 07 AMC	Avg Volume	33.05K	Price	16.11
SMA20	0.39%	SMA50	-1.53%	SMA200	7.89%	Trades		Volume	42,259	Change	-3.50%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-20-24	Upgrade	Jefferies	Hold → Buy	$2 → $35
Sep-13-21	Initiated	H.C. Wainwright	Neutral	$3.50
Sep-02-21	Downgrade	William Blair	Outperform → Mkt Perform
Mar-23-21	Downgrade	SVB Leerink	Outperform → Mkt Perform
Nov-06-20	Downgrade	Jefferies	Buy → Hold	$30 → $10
Oct-19-20	Initiated	Truist	Buy	$55
Oct-16-19	Initiated	Mizuho	Buy	$20
Nov-19-18	Initiated	Leerink Partners	Outperform	$45
Oct-08-18	Upgrade	B. Riley FBR	Neutral → Buy	$42
Aug-08-18	Initiated	Robert W. Baird	Outperform	$74
Apr-13-18	Downgrade	Chardan Capital Markets	Buy → Neutral	$35 → $50
Jan-05-18	Initiated	B. Riley FBR, Inc.	Neutral	$35
Nov-08-17	Initiated	Jefferies	Buy	$50
May-30-17	Initiated	Chardan Capital Markets	Buy	$35

Show Previous Ratings

Nov-07-24 06:19PM	Assembly Biosciences: Q3 Earnings Snapshot (Associated Press Finance) +5.11%
04:05PM	Assembly Biosciences Reports Third Quarter 2024 Financial Results and Recent Updates (GlobeNewswire)
Sep-23-24 01:39PM	Assembly Biosciences' Investigational Herpes Treatment Shows Safety In Healthy Participants (UPDATED) (Benzinga) -16.31%
08:00AM	Assembly Biosciences Reports Positive Interim Phase 1a Results from Clinical Trial Evaluating Long-Acting Helicase-Primase Inhibitor Candidate ABI-5366 (GlobeNewswire)
Sep-16-24 09:40AM	Is Assembly Biosciences (ASMB) Stock Outpacing Its Medical Peers This Year? (Zacks)
05:22PM	Loading…
Aug-08-24 05:22PM	Assembly Biosciences: Q2 Earnings Snapshot (Associated Press Finance) +6.02%
04:05PM	Assembly Biosciences Reports Second Quarter 2024 Financial Results and Recent Updates (GlobeNewswire)
Jul-15-24 08:00AM	Assembly Biosciences Presents New Preclinical Data Highlighting Investigational Helicase-Primase Inhibitors at International Herpesvirus Workshop (GlobeNewswire)
Jun-18-24 08:00AM	Assembly Biosciences Doses First Participant in Phase 1b Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 for the Treatment of Chronic Hepatitis B Virus Infection (GlobeNewswire)
Jun-17-24 08:00AM	Assembly Biosciences Announces $12.6 Million in Equity Financings (GlobeNewswire)
Jun-10-24 08:00AM	Assembly Biosciences Doses First Participant in Phase 1a/b Clinical Trial of Herpes Simplex Virus Helicase-Primase Inhibitor Candidate ABI-5366 (GlobeNewswire) +6.51%
Jun-05-24 08:00AM	Assembly Biosciences Presents New Data Highlighting Hepatitis D Virus Entry Inhibitor ABI-6250 at the EASL Congress 2024 (GlobeNewswire)
May-22-24 08:00AM	Assembly Biosciences to Present Data at Upcoming International Herpesvirus Workshop and EASL Congress 2024 (GlobeNewswire)
May-13-24 08:53AM	ASMB Stock Earnings: Assembly Biosciences Beats EPS for Q1 2024 (InvestorPlace)
May-09-24 05:04AM	Assembly Biosciences: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Loading…
May-08-24 04:05PM	Assembly Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights (GlobeNewswire)
Mar-28-24 10:53PM	ASMB Stock Earnings: Assembly Biosciences Beats EPS for Q4 2023 (InvestorPlace)
04:05PM	Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent Highlights (GlobeNewswire)
Mar-25-24 12:52PM	ASMB Stock Earnings: Assembly Biosciences Misses EPS for Q2 2023 (InvestorPlace)
Feb-08-24 08:00AM	Assembly Biosciences Announces Effective Date of Reverse Stock Split (GlobeNewswire)
Jan-04-24 08:00AM	Assembly Biosciences Provides Anticipated Development Milestones for 2024 (GlobeNewswire)
Nov-10-23 04:05PM	Assembly Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -6.11%
08:00AM	Assembly Biosciences Presents New Data Highlighting Viral Hepatitis Portfolio at AASLD The Liver Meeting (GlobeNewswire)
Nov-08-23 05:08PM	Assembly Biosciences: Q3 Earnings Snapshot (Associated Press Finance) -12.48%
04:05PM	Assembly Biosciences Reports Third Quarter 2023 Financial Results and Recent Updates (GlobeNewswire)
08:00AM	Assembly Biosciences Names Anuj Gaggar, MD, PhD, as Chief Medical Officer (GlobeNewswire)
Oct-17-23 10:59AM	Why Is Assembly Biosciences (ASMB) Stock Up 92% Today? (InvestorPlace) +72.18%
07:00AM	Gilead and Assembly Biosciences Establish Partnership to Develop Next-Generation Therapeutics for Serious Viral Diseases (Business Wire)
Oct-11-23 08:00AM	Assembly Biosciences to Present New Data at AASLD The Liver Meeting (GlobeNewswire)
Oct-02-23 08:00AM	Assembly Biosciences Nominates Development Candidate ABI-6250, an Orally Bioavailable HDV Entry Inhibitor (GlobeNewswire)
04:05PM	Loading…
Sep-19-23 04:05PM	Assembly Biosciences to Highlight Pipeline Progress in HBV and HDV at the 2023 International HBV Meeting (GlobeNewswire) -5.72%
Aug-09-23 06:11PM	Assembly Biosciences: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Assembly Biosciences Reports Second Quarter 2023 Financial Results and Recent Updates (GlobeNewswire)
Jul-17-23 08:00AM	Assembly Biosciences Presents New Data Highlighting Herpes Simplex Virus Development Candidate ABI-5366 at the 47th Annual International Herpesvirus Workshop (GlobeNewswire)
Jun-21-23 08:00AM	Assembly Biosciences Presents New Data Highlighting Entry Inhibitor and Core Inhibitor Programs at EASLs International Liver Congress 2023 (GlobeNewswire)
Jun-07-23 08:00AM	Assembly Biosciences to Present Data at Upcoming International Herpesvirus Workshop and EASL International Liver Congress 2023 (GlobeNewswire)
May-23-23 04:05PM	Assembly Biosciences to Present During the 2023 Jefferies Healthcare Conference (GlobeNewswire)
May-04-23 06:28PM	Assembly Biosciences: Q1 Earnings Snapshot (AP Finance)
04:05PM	Assembly Biosciences Reports First Quarter 2023 Financial Results and Recent Highlights (GlobeNewswire)
Apr-18-23 08:00AM	Assembly Biosciences Announces Additional Promising Data from Phase 1a Clinical Trial Evaluating Highly Potent Next-Generation Core Inhibitor Candidate ABI-4334 and Provides Pipeline Update (GlobeNewswire)
Mar-30-23 10:04AM	Companies Like Assembly Biosciences (NASDAQ:ASMB) Could Be Quite Risky (Simply Wall St.) -10.11%
Mar-22-23 04:05PM	Assembly Biosciences Provides Update on its Core Inhibitor Pipeline, Reports Fourth Quarter and Year End 2022 Financial Results and Recent Highlights (GlobeNewswire) -8.55%
Feb-15-23 08:00AM	Assembly Biosciences Nominates First Herpesvirus Development Candidate ABI-5366, a Long-Acting HSV-2 Helicase Inhibitor Targeting High-Recurrence Genital Herpes (GlobeNewswire)
Dec-19-22 03:19PM	Assembly Biosciences Shares Gain After Promising Early Cut Data From HBV Infection Programs (Benzinga) +14.53%
08:00AM	Assembly Biosciences Announces Promising Interim Results from Two Clinical Trials Evaluating Highly Potent Next-Generation Core Inhibitor Candidates ABI-H3733 and ABI-4334 (GlobeNewswire)
Nov-14-22 08:00AM	Assembly Biosciences Doses First Subject in Phase 1a Clinical Trial to Evaluate Safety, Tolerability and Pharmacokinetic Profile of Investigational Next Generation Core Inhibitor ABI-4334 (GlobeNewswire) +8.21%
Nov-09-22 09:35AM	After Plunging 17% in 4 Weeks, Here's Why the Trend Might Reverse for Assembly Biosciences (ASMB) (Zacks)
Nov-08-22 04:05PM	Assembly Biosciences Reports Third Quarter 2022 Financial Results and Recent Highlights and Announces Upcoming Conference Participation (GlobeNewswire) -7.43%
Nov-04-22 08:00AM	Assembly Biosciences Presents New Data at AASLD The Liver Meeting® Highlighting Breadth of Virology Portfolio and Potential of Next-Generation Core Inhibitors in HBV (GlobeNewswire) -5.00%
Oct-24-22 08:00AM	Assembly Biosciences to Present Data in Four Poster Presentations at Upcoming AASLD The Liver Meeting® (GlobeNewswire)
Oct-21-22 09:36AM	Can Assembly Biosciences (NASDAQ:ASMB) Afford To Invest In Growth? (Simply Wall St.)
Oct-05-22 04:05PM	Assembly Bio Announces Retirement of John G. McHutchison, AO, MD as CEO and Appoints Current President and COO Jason A. Okazaki as Successor (GlobeNewswire)
Aug-24-22 08:00AM	Assembly Biosciences to Host Webcast on August 31, 2022, Introducing Two New Research Programs Targeting Recurrent HSV-2 Infection and Transplant-Associated Herpesvirus Diseases (GlobeNewswire)
Aug-09-22 04:05PM	Assembly Biosciences Reports Second Quarter 2022 Financial Results and Recent Highlights (GlobeNewswire)
Aug-04-22 12:00PM	Assembly Biosciences (ASMB) Upgraded to Strong Buy: Here's Why (Zacks)
10:00AM	Best Momentum Stocks to Buy for August 4th (Zacks)
06:27AM	New Strong Buy Stocks for August 4th (Zacks)
Jul-21-22 07:22AM	The past five years for Assembly Biosciences (NASDAQ:ASMB) investors has not been profitable (Simply Wall St.) +7.83%
06:26AM	Disappointing Data Forces Assembly Bio Stop Combo Trial For HBV Infection (Benzinga)
Jul-20-22 05:48PM	Peninsula biotech to cut 30 jobs as it shuts down one hepatitis B to focus on others (American City Business Journals)
04:05PM	Assembly Biosciences Announces Program Reprioritization and Organizational Update (GlobeNewswire)
Jun-22-22 08:00AM	Assembly Biosciences Presents New Data Highlighting Clinical Progress of Core Inhibitor Programs at EASLs International Liver Congress 2022 (GlobeNewswire)
07:00AM	7 Penny Stocks That Could Triple in 2022 (InvestorPlace)
Jun-21-22 08:00AM	Assembly Biosciences to Introduce New Small Molecule Liver-Focused Interferon- Receptor Agonist Research Program in Webcast on July 26, 2022 (GlobeNewswire)
Jun-08-22 08:00AM	Assembly Biosciences to Highlight Data from HBV Core Inhibitor Programs at EASLs International Liver Congress 2022 (GlobeNewswire)
07:58AM	What Type Of Shareholders Own The Most Number of Assembly Biosciences, Inc. (NASDAQ:ASMB) Shares? (Simply Wall St.)
Jun-06-22 08:00AM	Assembly Biosciences Initiates Phase 1b Clinical Trial Evaluating Next Generation Core Inhibitor ABI-H3733 for the Treatment of Chronic Hepatitis B Virus Infection (GlobeNewswire)
Jun-03-22 04:05PM	Assembly Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +5.13%
May-27-22 09:38AM	Billionaire Israel Englander Pulls the Trigger on These 2 Strong Buy Penny Stocks (TipRanks) +10.29%
May-25-22 11:06AM	Peninsula biotech breaks off hepatitis B deal after partner's drug falters (American City Business Journals)
May-12-22 04:05PM	Assembly Biosciences Reports First Quarter 2022 Financial Results and Recent Highlights (GlobeNewswire) +7.41% +6.21%
Apr-01-22 05:00PM	Assembly Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Mar-23-22 04:19PM	Here's Why Assembly Biosciences (NASDAQ:ASMB) Must Use Its Cash Wisely (Simply Wall St.)
Mar-21-22 08:00AM	Assembly Biosciences to Highlight New Research Program for HBV/HDV Entry Inhibition in Webcast on March 31, 2022 (GlobeNewswire) +12.29%
Mar-10-22 04:05PM	Assembly Biosciences Reports Fourth Quarter and Year End 2021 Financial Results and Recent Highlights (GlobeNewswire)
Feb-09-22 08:00AM	Assembly Biosciences to Present During the SVB Leerink 11th Annual Global Healthcare Conference (GlobeNewswire)
Jan-19-22 09:38PM	Marquette Asset Management, LLC Buys Vanguard Total Bond Market ETF, ARK Next Generation ... (GuruFocus.com)
Jan-07-22 05:00PM	Assembly Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jan-06-22 08:00AM	Assembly Biosciences Announces Presentation During the 2022 H.C. Wainwright BIOCONNECT Virtual Conference (GlobeNewswire)
Jan-04-22 08:00AM	Assembly Biosciences Outlines Anticipated 2022 Pipeline Development Milestones (GlobeNewswire)
Dec-07-21 10:00AM	Down 30.1% in 4 Weeks, Here's Why You Should You Buy the Dip in Assembly Biosciences (ASMB) (Zacks) +6.42%
Dec-03-21 05:00PM	Assembly Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -6.58%
Nov-12-21 08:00AM	Assembly Biosciences Presents New Data at AASLD The Liver Meeting Highlighting the Progress of its HBV Core Inhibitor Portfolio (GlobeNewswire)
Nov-04-21 04:05PM	Assembly Biosciences Reports Third Quarter 2021 Financial Results and Recent Highlights (GlobeNewswire)
Nov-01-21 10:32AM	Assembly Biosciences Abstracts Selected for Presentation at the Upcoming AASLD The Liver Meeting® (GlobeNewswire)
Oct-19-21 07:30AM	Antios Therapeutics and Assembly Biosciences Announce Clinical Collaboration Agreement to Evaluate the Combination of ATI-2173 and Vebicorvir in Patients with Chronic Hepatitis B Virus Infection (PR Newswire)
Oct-06-21 08:00AM	Assembly Bio Announces October Conference Participation (GlobeNewswire)
Oct-01-21 06:04PM	Assembly Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Sep-24-21 06:35AM	What Is The Ownership Structure Like For Assembly Biosciences, Inc. (NASDAQ:ASMB)? (Simply Wall St.)
Sep-02-21 03:18PM	Mid-Afternoon Market Update: Dow Rises 90 Points; Kirkland's Shares Spike Higher (Benzinga) -16.15%
12:05PM	Mid-Day Market Update: Crude Oil Jumps Over 2%; Assembly Biosciences Shares Plunge (Benzinga)
10:17AM	Mid-Morning Market Update: Markets Open Higher; Hormel Foods Cuts Earnings Outlook (Benzinga)
06:49AM	Assembly Bio Stock Tumbles On Discontinuation Of Hepatitis B Trial (Benzinga)
Sep-01-21 04:02PM	Assembly Bio Announces Decision to Discontinue Clinical Development of ABI-H2158 (GlobeNewswire)
Aug-18-21 08:00AM	Assembly Bio Selects Fourth HBV Core Inhibitor Candidate for Advancement Into Clinical Development (GlobeNewswire)
Aug-05-21 05:45PM	Assembly Biosciences (ASMB) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
04:01PM	Assembly Biosciences Reports Second Quarter 2021 Financial Results and Recent Highlights (GlobeNewswire)
Aug-03-21 08:00AM	Assembly Bio Announces Key Promotions to Leadership Team (GlobeNewswire) +5.48%
Jul-28-21 03:03PM	Analysts Estimate Assembly Biosciences (ASMB) to Report a Decline in Earnings: What to Look Out for (Zacks)
Jul-20-21 08:00AM	Nobel Laureate Dr. Michael Houghton Appointed to Assembly Biosciences Board of Directors (GlobeNewswire)

Assembly Biosciences, Inc. is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. It focuses on two innovative platform programs: oral therapeutics for the treatment of hepatitis B virus, and the oral synthetic live biotherapeutics candidate. The company was founded by Uri Lopatin and Derek A. Small on October 7, 2005 and is headquartered in South San Francisco, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Schornstein Alexander	10% Owner	Nov 22 '24	Buy	14.87	17,024	253,104	720,137	Nov 26 09:15 AM
Schornstein Alexander	10% Owner	Nov 25 '24	Buy	14.91	7,976	118,890	728,113	Nov 26 09:15 AM
White Nicole S	Chief Manufacturing Officer	Nov 18 '24	Sale	16.29	40	652	11,871	Nov 19 04:05 PM
Schornstein Alexander	10% Owner	Oct 08 '24	Buy	14.58	10,000	145,800	703,113	Oct 09 09:15 AM
White Nicole S	Chief Manufacturing Officer	Oct 03 '24	Sale	14.81	157	2,325	11,911	Oct 04 04:05 PM
Okazaki Jason A	CEO and President	Oct 03 '24	Sale	14.81	197	2,918	14,904	Oct 04 04:05 PM
White Nicole S	Chief Manufacturing Officer	Aug 02 '24	Sale	14.23	785	11,173	12,068	Aug 05 04:10 PM
Okazaki Jason A	CEO and President	Aug 02 '24	Sale	14.23	981	13,962	15,101	Aug 05 04:05 PM
Schornstein Alexander	10% Owner	Jul 03 '24	Buy	12.29	4,562	56,067	688,675	Jul 08 10:48 AM
Schornstein Alexander	10% Owner	Jul 05 '24	Buy	12.52	4,438	55,564	693,113	Jul 08 10:48 AM
Bjorkquist Jeanette M	Principal Accounting Officer	May 23 '24	Sale	14.93	24	358	3,142	May 24 04:10 PM
McHutchison John G	Director	May 23 '24	Sale	14.93	2,117	31,615	19,104	May 24 04:10 PM
White Nicole S	Chief Manufacturing Officer	May 23 '24	Sale	14.93	172	2,569	12,853	May 24 04:05 PM
Okazaki Jason A	CEO and President	May 23 '24	Sale	14.93	549	8,199	16,082	May 24 04:05 PM
White Nicole S	Chief Manufacturing Officer	Apr 30 '24	Sale	12.71	1,255	15,947	13,025	May 01 04:10 PM
Okazaki Jason A	CEO and President	Apr 30 '24	Sale	12.71	1,569	19,937	16,423	May 01 04:05 PM
McHutchison John G	Director	Apr 01 '24	Sale	13.07	1,206	15,765	21,221	Apr 02 04:25 PM
Bjorkquist Jeanette M	Principal Accounting Officer	Apr 01 '24	Sale	13.07	114	1,490	3,166	Apr 02 04:20 PM
White Nicole S	Chief Manufacturing Officer	Apr 01 '24	Sale	13.07	197	2,575	10,947	Apr 02 04:15 PM
Okazaki Jason A	CEO and President	Apr 01 '24	Sale	13.07	354	4,627	13,826	Apr 02 04:05 PM
Okazaki Jason A	CEO and President	Mar 27 '24	Sale	12.87	392	5,045	14,180	Mar 29 04:05 PM
Schornstein Alexander	10% Owner	Jan 18 '24	Buy	0.80	345,086	276,069	8,209,372	Jan 19 11:01 AM
Schornstein Alexander	10% Owner	Jan 17 '24	Buy	0.78	299,994	235,195	7,864,286	Jan 19 11:01 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ASMB

Assembly Biosciences Inc

Upgrade your FINVIZ experience